Human papillomavirus (HPV) infections result in a substantial burden of disease globally. HPV causes cancers in both men and women, particularly cancer of the cervix (in females), other anogenital cancers and certain cancers of the mouth and throat (in both males and females).
In 2007, Australia became one of the first countries to fund and implement a national HPV vaccination program which has had a significant impact on the incidence of HPV and associated disease, and now includes males as well as females .
This next NCIRS seminar/webinar will reflect on the success of the HPV vaccination program in Australia and explore opportunities for the future. Hear from some of Australia’s internationally recognised experts in the field.
Professor Rebecca Guy will present on the implementation and optimisation of HPV vaccination programs across Australia, with particular focus on school-based programs. Associate Professor Julia Brotherton will then discuss how we can make the greatest future impact on HPV-related cancer burden. Additionally, Cristyn Davies will present on the factors affecting HPV vaccination uptake in adolescents and how providers can support parent and adolescent decision-making toward vaccination.